Publicaciones › Edema macular diabético y sus tratamientos
Resolution of diabetic macular oedema following high altitude exercise
Resolución del edema macular diabético después del ejercicio en alta altitud
| Año | 2006 |
|---|---|
| Fuente | Acta ophthalmologica Scandinavica |
| Tipo | article · Case Reports, Letter |
| Autores (6) | Kristel Averous, Ali Erginay, José Timsit, Belkacème Haouchine, Alain Gaudric, Pascale Massin |
| Posición de Erginay | 2 de 6 |
| Citas | 13 (OpenAlex) |
| Enlaces | DOI 10.1111/j.1600-0420.2006.00701.x · PubMed 17083552 · OpenAlex |
| Líneas | Edema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Interfase vitreomacular, agujero macular y miopía alta Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo |
En pocas palabras
Se estudió el caso de una paciente con edema macular diabético que mejoró después de realizar ejercicio en alta altitud en Nepal. La paciente experimentó una mejora en su visión y una reducción en el grosor macular después de su regreso a nivel del mar. La terapia con oxígeno hiperbárico también mostró resultados beneficiosos en la reducción del edema macular.
Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.
Resumen original
Editor, Macular oedema is the main cause of visual impairment in diabetes patients, but standard treatments result in only limited success (Williams et al. 2004). We report here a case of macular oedema that exhibited an unusual evolution after trekking in Nepal. Hyperbaric oxygen therapy, which was performed after trekking, had a beneficial effect on this oedema. A 57-year-old woman with type 1 diabetes developed moderate proliferative diabetic retinopathy in her left eye in April 1998 and in her right eye in June 1999. Slow panretinal photocoagulation was started (one session every 2 months, extending from the equator to the ora). In August 1999, she complained of vision loss in both eyes. Visual acuity (VA) was 20/100 in both eyes, due to bilateral macular cystoid oedema. Grid laser photocoagulation, systemic corticotherapy and vitrectomy were performed but had no significant effect. In February 2002, VA was 20/200 in the right eye and 20/100 in the left; glycosylated haemoglobin (HbA1c) was 6%. Central macular thickness, measured by optical coherence tomography (Humphrey Instruments, Inc., Dublin, California, USA), was 640 µm in the right eye and 580 µm in the left. The patient then went trekking in Nepal for 1 month, at altitudes of up to 3000 metres. She did not use any oxygen supplements while trekking. She felt no improvement when climbing up nor while staying at high altitudes. She started to feel some improvement in her VA towards the end of her journey. One week after her return, VA had improved to 20/50 in the right eye and 20/80 in the left. Right and left eye macular thickness had decreased to 233 µm and 305 µm, respectively (Fig. 1); HbA1c remained the same at 6%. Diabetic macular edema. Evolution of macular edema after trekking in Nepal. Before trekking: (A): Right eye (RE), (B): Left eye (LE). Optical coherence tomography (OCT) shows macular edema with increased macular thickness, hyporeflectivity of the outer retinal layers, and intraretinal cysts. Macular thickness was 640 μm RE and 580 μm LE. Visual acuity was 20/200 RE and 20/100 LE. After trekking in Nepal: (C): Right eye, (D): Left eye. OCT showed a dramatic decrease in macular thickness in both eyes, with restoration of an almost normal macular profile in the RE; an epiretinal membrane is present in the left eye. Macular thickness was 233 μm RE and 305 μm LE. Visual acuity was 20/50 RE and 20/80 LE. Three months later, VA gradually decreased again to 20/125 in the right eye and 20/320 in the left. Macular thickness was 620 µm in the right eye and 580 µm in the left. Hyperbaric oxygen therapy was initiated (14 sessions over 1 month) and resulted in decreased macular thickness (233 µm in the right eye and 305 µm in the left) and improved VA (20/63 in the right eye and 20/160 in the left). Macular oedema recurred 1 month later, and again resolved with hyperbaric oxygen therapy. During the 3 years that followed, several macular oedema recurrences were treated with hyperbaric oxygen therapy, always with good results (Fig. 2). Variations of macular thickness measured with OCT before and after Nepal and hyperbaric oxygenotherapy. The improvement in this patient's VA after prolonged high-altitude exercise was quite remarkable. At high altitudes, the production of red cells increases in order to maintain the oxygen supply to the tissues. When our patient returned to sea level, she may have benefited from this polyglobully, which resulted in improved tissue oxygenation. The evolution of the present case therefore suggests that retinal hypoxia is involved in the pathogenesis of macular oedema, as suggested by Nguyen et al. (2004). Hypoxia may indeed cause changes in retinal blood flow and vessel resistances that lead to increased passage of fluid into the extracellular spaces (according to Starling's law; Diroll [2003]). Hypoxia also raises the production of growth factors, such as vascular endothelial growth factor, involved in the breakdown of the blood–retinal barrier (Antonetti et al. 1999). Consequently, after the recurrence of macular oedema in our patient, we had two options for improving tissue oxygenation: hyperbaric oxygen therapy or erythropoietin (Friedman et al. 1995). The beneficial effect of hyperbaric oxygen therapy on macular oedema of various origins has been documented in case reports (Kiryu & Ogura 1996; Suttorp-Schulten et al. 1997). Supplemental oxygen has also been found to improve the condition of patients with chronic diabetic macular oedema (Nguyen et al. 2004). Hyperbaric oxygen therapy hyperoxygenates the tissues, constricts retinal blood vessels and may thus have a favourable effect on cystoid macular oedema. Here, we observed this beneficial effect, which was reproducible over a 3-year period.